TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Proportion of patients who stop one or more medications
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse events (AE)/severe adverse events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Objective response rate (ORR) (RECIST 1.1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Recommended Phase 2 Dose (RP2D)
Endpoint domain: Physiological/clinical
Primary endpoint: Postoperative abdominal infection
Endpoint domain: Adverse events/effects
Primary endpoint: Cardiac death or non-fatal spontaneous target-vessel myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Dysplasia Detection Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: post surgical complications
Endpoint domain: Adverse events/effects
Primary endpoint: change in autonomic dysreflexia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Respiratory symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Common carotid artery flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Average deviations in localization of perforators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate in estimating proper dissecting strategy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline ASIA scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Visuel Analog Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Change From Baseline in Corneal Fluorescein Staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amino acids metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Central carbon metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Self-rated Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Blood Glucose Measurements Recorded
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Blood Pressure Measurements Recorded
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tissue concentrations of vancomycin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Esophageal pressure changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Midluteal bacterial composition of endometrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Successful consent and enrollment of participants
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Completion of online self-reported questionnaires
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Utility and informativeness of data collected
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Intervention success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Concentration (Cmax) of Olpasiran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve (AUC) of Olpasiran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Half-life (t1/2) of Olpasiran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Numeric Rating Scale (NRS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change From Baseline in Wrist Modified Ashworth Scale-Bohannon (MAS-B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Difference in health status between COVID and healthy group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage point change on the probability of new vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical Outcome Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasal Obstruction Symptom Evaluation (NOSE) Instrument
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Nasal Appearance and Function Evaluation Questionnaire (NAFEQ) Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in IOWA Connors Rating Scale (IOWA-CRS) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Impairment Rating Scale (IRS) Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Parental Stress - Short Form (PSI-SF) Total Stress Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual Analogue Scale for Hunger
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Visual Analogue Scale for Fullness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Visual Analogue Scale for Satiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Visual Analogue Scale for Desire to Eat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Visual Analogue Scale for Prospective Consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Visual Analogue Scale for Satisfaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to first requested rescue analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of Progression Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Overall survival from time of diagnosis
Endpoint domain: Mortality/survival
Primary endpoint: Toxicity measured using CTCAE v5
Endpoint domain: Adverse events/effects
Primary endpoint: Serial bacterial gene markers changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Serial gut microbiome changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory resistance R5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Expiratory resistance (R5exp)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Resistance at low expiratory flow (Reo2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: COPD Assessment Test (CAT) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: kick velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital revisits (Emergency Department or Inpatient)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: 6 minute walk test (6mwt)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax after single dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-last after single dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: t1/2 after single dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in the weekly mean of the daily 24-hour WI-NRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated Rate of PRC-PWUO Contact
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of AI-Driven Texting Use Among PWUO
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Amount of time to Initial Receipt of Buprenorphine (Self-Reported)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Need for recovery after work
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Prevalence of functional gastrointestinal disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of patients with thymidine kinase activity (TKa) values switching profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of improvement in CDK4/6 inhibitor response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone mineral content (BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Physical Variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of Smoking Reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Device-Related Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients with Technical Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Patients Without Rupture or Dissection of the Treated Vessel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Mean SALT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SALT50
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SALT75
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Appointments with PROMIS Scores Documented
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of intrauterine growth retardation (IUGR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Percentage of viability of nasal epithelial cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial Anxiety Scale (FAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Edmonton Symptom Diagnostic Scale (ESAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vital parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of ≥ grade 3 treatment-related adverse events (TRAE)
Endpoint domain: Adverse events/effects
Primary endpoint: PFS rate at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Area Under the Plasma Concentration-time Curve from Time 0 to Infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCinf of ecopipam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-143 of ecopipam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Joint pain visual analog scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in foveal avascular zone area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in vascular density of the superficial retinal capillary plexus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in vascular density of the deep retinal capillary plexus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Time of patient stay at Emergency Department
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change from baseline in PANSS positive subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of counseling sessions attended
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completion of therapy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bullying
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Class environment
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Relative lower limbs muscle power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vital functional capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of physical activity during the daily life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of participants reporting Serious Adverse Events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Total number of Adverse Events (AE) reported
Endpoint domain: Adverse events/effects
Primary endpoint: Analgesia nociception index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Star exclusion test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Finger tip to floor test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximum tolerated dose of oral azacitidine (CC-486)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall response rate (complete response [CR] + partial response [PR])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Motion sickness assessment questionnaire: gastrointestinal subscore
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Motion sickness assessment questionnaire: total subscore
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in plasma uric acid level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 30-sec sit and go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportions of patients reaching MCID for NRS leg
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Blood volume drawn
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Dose delivery efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dimensional changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of intensive care department stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in TOF ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive value of the heart risk 6 scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: The University of California-Los Angeles (UCLA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The 12 item Short Form Survey (SF-12)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Correlation between ultrasonography and clinical tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under drug time curve (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under drug time curve (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extent of wound (wound surface area)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Direct measurement of volume (Depth of wound)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Linear mesio-distal position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Linear occlusal-gingival position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ergonomics awareness level
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: First aid knowledge level
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: bullying tendency
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: bullying victimization
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-Reported Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decreasing serum phosphorus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average motor unit firing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of major cardiovascular adverse events (MACE)
Endpoint domain: Adverse events/effects
Primary endpoint: 30-day booster vaccine uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Muscle glucose uptake (pre-exercise)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Muscle glucose uptake (post-exercise)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients/teeth displaying furcation closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative change of cardiac output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Arterial PCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Efficacy of treatment with Esketamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of children's lives
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: General health assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in plasma IFN-γ level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in plasma TNF-α level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in plasma IL-4 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in plasma IL-17A level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in plasma IL-10 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in plasma Transforming Growth Factor (TGF)-β level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in Pediatric Eosinophilic Esophagitis Symptom Severity Module (PEESS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Endoscopic scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Histological scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of patients that complete the study
Endpoint domain: Mortality/survival
Primary endpoint: Overall experience based qualitative semi-structured interview
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Wijma Birth Expectation/Experience Scale (W-DEQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-Efficacy Scale in Labor
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Birth Memory and Recall Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Muscle function status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PRO-C3 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cue-reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity in detection of recurrent colonic advanced adenomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Quality-of-life related to postpartum thromboprophylaxis
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Tumor progression score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Summed Pain Intensity Difference 0-8 hours (SPID0-8)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Meaningful pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with abnormal MRI findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Nausea & Vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of influenza/other acute respiratory viral infection
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants abstinent from alcohol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance to the Personalized Prevention Plan
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total pathologic complete response (tPCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: five-year wear thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported urge for internet gaming
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in score on the Menopause Rating Scale (MRS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in hot flashes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: neurophysiological indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: neuropsychological indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: behavioral indicators
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing